NCT00163371View on ClinicalTrials.gov

Effects of Inhaled Ciclesonide Versus Fluticasone Propionate Versus Placebo on Lower Leg Growth in Prepubertal Children With Mild Persistent Asthma (6 to 12 y) (BY9010/M1-208)

PHASE3CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions
Asthma
Interventions
DRUG

Ciclesonide

Trial Locations (1)

6000

Altana Pharma/Nycomed, Kolding

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT00163371 - Effects of Inhaled Ciclesonide Versus Fluticasone Propionate Versus Placebo on Lower Leg Growth in Prepubertal Children With Mild Persistent Asthma (6 to 12 y) (BY9010/M1-208) | Biotech Hunter | Biotech Hunter